IDEXX Labs (IDXX) Tops Q2 EPS by 34c, updates guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
IDEXX Laboratories (IDXX) PT Raised to $785 at Jefferies
August 5, 2025 6:21 AM EDTJefferies analyst Keith Devas raised the price target on IDEXX Laboratories (NASDAQ: IDXX) to $785.00 (from $625.00) while maintaining a Buy rating.
The analyst comments "Strong 2Q results (sales +10.6%, EBITDA +14%) and higher guidance confirms the innovation playbook is working. Management's decision to pull-forward spend in... More
